No Detail Found!

Diagnostic Accuracy of Anti-endomysial Antibody in Celiac Disease.

Author(s)
Arslaan Javaeed Department of Pathology, Fatima Memorial College of Medicine and Dentistry, Lahore, Pakistan
Walayat Shah Department of Histopathology, Institute of Basic Medical Sciences, Khyber Medical University, Peshawar, Pakistan
Sanniya Khan Ghauri Department of Medicine, the Aga Khan University Hospital, Karachi, Pakistan
Rizwan Akhtar Department of Pathology, Fatima Memorial College of Medicine and Dentistry, Lahore, Pakistan
Abstract
The objective of the study was to determine the diagnostic accuracy of anti-EMA antibody in comparison to histopathological findings in patients suspected of CD. This cross-sectional study was conducted at Gastroenterology Department, Fatima Memorial Hospital, Lahore, from March to October 2014. One hundred and twenty-one patients aged between 5 - 60 years of either gender were recruited in the study. Every patient went through serological testing and biopsy specimens were obtained from second part of the duodenum. Histopathological evaluation was done according to the Modified Marsh classification. The overall sensitivity of anti-EMA came out to be 85.7% which varied with the histological lesions being 75.0%, 83.3%, and 100% for Marsh IIIA, IIIB and IIIC, respectively. Although anti-EMA has high sensitivity but serological tests as a sole mean of diagnosis are currently unable to replace the biopsy.
Publication Details
Page(s) 541-542
DOI DOI not available
Published Journal: Journal of College of Physicians and Surgeons--Pakistan : JCPSP, Volume: 26, Issue: 6, Year: 2016

Request the full text from PASTIC

Keywords
Celiac disease. Anti-endomysial antibody. Duodenal biopsy. Marsh classification
References
Van der WindtDA, 2010.Diagnostic testing for celiac disease among patients with abdominal symptoms: a systematic review,JAMA 303 1738 -46
KapitányA,TóthL,TumpekJ,CsípoI,SiposE,WoolleyN, 2006.Diagnostic significance of HLA-DQ typing in patients with previous celiac disease diagnosis based on histology alone,Aliment Pharmacol Therap 24 1395 -402
FiasanoA,CarloC, 2001.Current approaches to diagnosis and treatment of celiac disease; an evolving spectrum,Gastroenterology 120 636 -51
AnittaR,KatriK., 2012.Positive serum antigliadin antibodies without celiac disease in the elderly population: does it matter?,Scand J Gastroenterol 45 1197 -201
MankaiA,SaklyW,LandolsiH, 2005.Tissue transglutaminase antibodies in celiac disease, comparison of an enzyme linked immunosorbent assay and a dot blot assay,Pathol Biol 53 204 -9
WangN,TruedssonL,ElvinK,AnderssonB,RönnelidJ,Mincheva-NilssonL, 2014.Serological assessment for celiac disease in IgA deficient adults,PLoS One 9 e93180 -
OberhuberG,GranditschG,VogelsangH., 1999.The histopathology of celiac disease: time for a standardized report scheme for pathologists,Eur J Gastroenterol Hepatol 11 1185 -94
RostamiK,KerckhaertJ,TiemessenR,von BlombergM,MeijerW,MulderJ, 1999.Sensitivity of endomysium and antigliadin antibodies in untreated celiac disease: disappointing in clinical practice,Am J Gastroenterol 94 888 -94
TarmureS,CristeaA,SampeleanD,NegreanV,AlexescuT., 2007.Serological and histological correlations in celiac disease,Rom J Intern Med 45 263 -8
HussainS,SabirM,AfzalM,AsgharI., 2014.Celiac disease: clinical presentation and diagnosis by anti-tissue transglutaminase antibodies titer in children,JPMA 64 437 -
0

Citations

0

Downloads

90

Views